JK Tyre & Industries Limited (NSE:JKTYRE)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,865	1,713	1,732	940.5	889.7
Short-Term Investments	112.9	112.3	111.7	-	-
Cash & Short-Term Investments	1,978	1,826	1,843	940.5	889.7
Cash Growth	8.37%	-0.96%	95.98%	5.71%	35.98%
Accounts Receivable	28,313	27,544	22,832	19,799	15,754
Other Receivables	1,632	1,270	1,963	1,082	1,103
Receivables	29,945	28,815	24,795	20,881	16,858
Inventory	25,256	22,816	21,705	24,326	17,893
Prepaid Expenses	252.2	244	264.2	327.9	378.6
Other Current Assets	12,104	11,866	5,507	6,863	4,901
Total Current Assets	69,535	65,566	54,115	53,339	40,920
Property, Plant & Equipment	69,411	69,280	63,994	62,985	63,054
Long-Term Investments	1,114	1,271	1,328	1,328	1,470
Goodwill	171.7	-	-	-	-
Other Intangible Assets	2,064	2,624	2,571	2,311	2,304
Long-Term Deferred Tax Assets	841.1	829.1	1,095	869.2	462.5
Long-Term Deferred Charges	35.5	38.8	59.1	70.5	122.7
Other Long-Term Assets	2,017	1,336	1,323	1,575	1,534
Total Assets	145,189	140,945	124,486	122,477	109,867
Accounts Payable	18,921	21,572	18,196	21,885	15,741
Accrued Expenses	10,228	10,205	8,486	6,245	6,805
Short-Term Debt	23,780	18,766	19,411	20,442	11,556
Current Portion of Long-Term Debt	3,858	4,099	4,821	5,951	6,402
Current Portion of Leases	411.5	381.9	435.5	401.8	502.3
Current Income Taxes Payable	1.3	349	615.4	368	15.7
Current Unearned Revenue	263.7	269	281.7	342.1	276.4
Other Current Liabilities	533.8	1,215	362.3	344.6	389.3
Total Current Liabilities	57,997	56,858	52,609	55,979	41,687
Long-Term Debt	20,282	21,869	23,604	24,759	28,607
Long-Term Leases	780.7	978.6	552.6	650	939.8
Long-Term Unearned Revenue	9,088	8,230	7,460	6,364	6,121
Long-Term Deferred Tax Liabilities	6,084	5,768	4,306	4,051	3,683
Total Liabilities	95,352	94,884	89,527	93,002	82,077
Common Stock	548	521.4	492.5	492.5	492.5
Additional Paid-In Capital	11,685	9,446	4,559	4,559	4,559
Retained Earnings	36,345	31,760	26,194	23,939	22,346
Comprehensive Income & Other	-74.1	3,139	2,716	-507.1	-670
Total Common Equity	48,504	44,867	33,962	28,483	26,727
Minority Interest	1,333	1,193	997.2	991.6	1,063
Shareholders' Equity	49,837	46,061	34,959	29,475	27,790
Total Liabilities & Equity	145,189	140,945	124,486	122,477	109,867
Total Debt	49,112	46,095	48,824	52,204	48,007
Net Cash (Debt)	-47,133	-44,269	-46,980	-51,263	-47,117
Net Cash Per Share	-171.64	-167.22	-190.43	-208.19	-191.35
Filing Date Shares Outstanding	274.02	260.72	246.23	246.23	246.23
Total Common Shares Outstanding	274.02	260.72	246.23	246.23	246.23
Working Capital	11,538	8,708	1,506	-2,640	-766.9
Book Value Per Share	177.01	172.09	137.93	115.68	108.55
Tangible Book Value	46,268	42,243	31,390	26,172	24,423
Tangible Book Value Per Share	168.85	162.02	127.48	106.29	99.19
Land	5,916	6,205	6,054	5,853	5,775
Buildings	13,279	12,991	12,439	12,148	12,018
Machinery	94,037	92,150	85,905	81,830	76,530
Construction In Progress	4,173	3,658	1,906	1,006	2,864

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.